靶点新药-话题@MedSci

#靶点新药#

3篇内容 | 256人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1819857, encodeId=9e2f181985e20, content=<a href='/topic/show?id=498799968fe' target=_blank style='color:#2F92EE;'>#靶点新药#</a>, objectTitle=肝胆领域值得期待三大靶点新药介绍，让肝癌患者有更多的选择！, objectType=article, longId=193462, objectId=57141934627d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57141934627d, replyNumber=0, likeNumber=41, createdTime=2021-04-13, rootId=0, userName=医生2394, userId=b505306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57141934627d, moduleTitle=肝胆领域值得期待三大靶点新药介绍，让肝癌患者有更多的选择！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57141934627d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819856, encodeId=ec001819856fd, content=<a href='/topic/show?id=498799968fe' target=_blank style='color:#2F92EE;'>#靶点新药#</a>, objectTitle=Mol Cancer Ther:对抗三阴乳腺癌化疗耐药性，MPS1靶点新药“重振”紫杉醇功效, objectType=article, longId=181276, objectId=58ec1812e693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58ec1812e693, replyNumber=0, likeNumber=34, createdTime=2020-09-27, rootId=0, userName=医生2394, userId=b505306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58ec1812e693, moduleTitle=Mol Cancer Ther:对抗三阴乳腺癌化疗耐药性，MPS1靶点新药“重振”紫杉醇功效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58ec1812e693)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819855, encodeId=7de01819855b5, content=<a href='/topic/show?id=498799968fe' target=_blank style='color:#2F92EE;'>#靶点新药#</a>, objectTitle=十大热门靶点新药销售收入对比, objectType=article, longId=161395, objectId=f06c1613956c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f06c1613956c, replyNumber=0, likeNumber=26, createdTime=2019-11-22, rootId=0, userName=医生2394, userId=b505306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f06c1613956c, moduleTitle=十大热门靶点新药销售收入对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f06c1613956c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

靶点新药

2020-05-29

医生2394 (审核中...)

前往app查看评论内容

#靶点新药#

肝胆领域值得期待三大靶点新药介绍，让肝癌患者有更多的选择！

2021-04-13

医生2394 (审核中...)

前往app查看评论内容

#靶点新药#

Mol Cancer Ther:对抗三阴乳腺癌化疗耐药性，MPS1靶点新药“重振”紫杉醇功效

2020-09-27

医生2394 (审核中...)

前往app查看评论内容

#靶点新药#

十大热门靶点新药销售收入对比

2019-11-22

科室
- - 订阅+
  - 更多科室
工具
服务